Abstracts tagged "quality improvement"

Abstract Number: 1797 • 2017 ACR/ARHP Annual Meeting
Insights from Treating to Target in Rheumatoid Arthritis at an Academic Medical Center
Malithi Jayasundara¹, Ryan Jessee², Jason Weiner³, Tayseer Haroun⁴, Stephanie Giattino⁵, Atul Kapila⁴, Jenelle Hall⁴, Lisa Carnago⁴ and Lisa Criscione-Schreiber⁶, ¹Rheumatology, Duke University, Durham, NC, ²Department of Medicine, Division of Rheumatology and Immunology, Duke University, Durham, NC, ³Department of Medicine, Division of Rheumatology and Immunology, Duke University Medical Center, Durham, NC, ⁴Duke University, Durham, NC, ⁵Rheumatology, Duke University Medical Center, Durham, NC, ⁶Internal Medicine, Duke University Medical Center, Durham, NC
Background/Purpose: Current RA guidelines recommend treating to a target of remission or low disease activity (RM/LDA) state. In a prior quality improvement (QI) project, our…
Abstract Number: 1798 • 2017 ACR/ARHP Annual Meeting
Effective Implementation and Evaluation of Quality Improvement Initiatives in a Safety Net Hospital Rheumatology Clinic
Alfredo Aguirre¹, Laura Trupin², Mary Margaretten³, Sarah Goglin⁴ and Jinoos Yazdany², ¹Internal Medicine, University of California, San Francisco, SAN FRANCISCO, CA, ²Medicine/Rheumatology, University of California San Francisco, San Francisco, CA, ³Medicine, University of California San Francisco, San Francisco, CA, ⁴Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA
Background/Purpose: Vulnerable populations with autoimmune rheumatic diseases are at higher risk for disparities in care. To address these health inequalities we developed and evaluated 2…
Abstract Number: 422 • 2016 ACR/ARHP Annual Meeting
Developing a Staff-Driven Electronic Smoking Cessation Referral Program in Rheumatology Clinics
Daniel Panyard¹, Edmond Ramly², Andrea Gilmore-Bykovskyi³, Diane Lauver³, Robert Adsit⁴, Courtney Maxcy⁵ and Christie M. Bartels⁶, ¹Population Health, University of Wisconsin School of Medicine and Public Health, Madison, WI, ²Industrial and Systems Engineering, University of Wisconsin-Madison College of Engineering, Madison, WI, ³University of Wisconsin-Madison School of Nursing, Madison, WI, ⁴University of Wisconsin Center for Tobacco Research and Intervention, Madison, WI, ⁵University of Wisconsin, Madison, WI, ⁶Rheumatology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI
Background/Purpose: Patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) have an increased risk of premature cardiovascular disease (CVD), making comorbid risk factors like…
Abstract Number: 427 • 2016 ACR/ARHP Annual Meeting
Identifying Barriers to Zoster Vaccination Rates Among RA Patients in an Academic Rheumatology Practice
Ami Joglekar¹, Ashley Blaske² and Narender Annapureddy³, ¹Department of Medicine, Division of Rheumatology, Vanderbilt University, Nashville, TN, ²Internal Medicine/Pediatrics, Vanderbilt University, Nashville, TN, ³Vanderbilt University, Nashville, TN
Background/Purpose: The risk of herpes zoster (HZ) infection in patients with rheumatic disease is 1.5 to 2 times that of the general population. The 2012 ACR Treatment…
Abstract Number: 430 • 2016 ACR/ARHP Annual Meeting
A Process to Obtain Hepatitis B Serology Screening on Immunocompromised Pediatric Rheumatology Patients
Emily Smitherman¹, Leslie A. Favier¹, Adam Furnier², Sandra Kramer³, Barbara Speer⁴, John Kues⁴, Lara Danziger-Isakov³, Rebecca Brady⁵ and Jennifer L. Huggins⁶, ¹Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ²James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ³Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁴University of Cincinnati, Cincinnati, OH, ⁵Division of infectious diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁶Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Background/Purpose: In the setting of today’s heroin epidemic, hepatitis B infection remains a significant public health concern, especially for patients with immunocompromising conditions. With reports…
Abstract Number: 434 • 2016 ACR/ARHP Annual Meeting
Nurse Scheduled Telephone Visit: The Right Rheumatology Care for the Right Patient at the Right Time
Shazdeh Butt¹, Eric Newman² and Natasha Smith¹, ¹Rheumatology, Geisinger Medical Center, Danville, PA, ²Department of Rheumatology, Geisinger Medical Center, Danville, PA
Background/Purpose: Rising healthcare costs have resulted in greater patient burden, higher health insurance costs, deductibles, and copayments. Access to care is delayed and problematic. Many…
Abstract Number: 1404 • 2016 ACR/ARHP Annual Meeting
Systematic Review and Appraisal of Quality Measures for Inflammatory Arthritis
Matthew Cooper¹ and Claire E H Barber², ¹University of Calgary, Calgary, AB, Canada, ²Rheumatology, University of Calgary, Calgary, AB, Canada
Background/Purpose: Quality measures are metrics health professionals can monitor to improve care delivery and patient outcomes. To be measurable they must include a specified numerator,…
Abstract Number: 3214 • 2016 ACR/ARHP Annual Meeting
Implementation of Treat to Target in Rheumatoid Arthritis through a Learning Collaborative
Daniel H. Solomon¹, Bing Lu², Elena Losina³, Jen Agosti⁴, Agnes Zak⁵, Cassandra Corrigan⁵, Zhi Yu⁶, Sara Lee⁵, Asaf Bitton⁷, LR Harrold⁸, Theodore Pincus⁹, Helga Radner¹⁰, Josef Smolen¹¹, Liana Fraenkel¹² and Jeffrey N. Katz¹³, ¹Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ²Brigham & Women's Hospital and Harvard Medical School, Boston, MA, ³Orthopaedic and Arthritis Center for Outcomes Research, Department of Orthopaedic Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, ⁴JRA Consulting, Andover, MA, ⁵Brigham and Women's Hospital, Boston, MA, ⁶Rheumatology Immunology & Allergy, Brigham and Women's Hospital, Boston, MA, ⁷Medicine, Brigham and Women's Hospital, Boston, MA, ⁸University of Massachusetts Medical School, Worcester, MA, ⁹Rheumatology, Rush University Medical Center, Chicago, IL, ¹⁰Rheumatology, Medical University of Vienna, Vienna, Austria, ¹¹Division of Rheumatology, Medical University of Vienna and Hietzing Hospital, Vienna, Austria, ¹²Yale University School of Medicine, New Haven, CT, ¹³Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, Boston, MA
Background/Purpose: Treat to target (TTT) is a recommended strategy in the management of rheumatoid arthritis (RA), but various studies suggest that its uptake in routine…
Abstract Number: 2541 • 2015 ACR/ARHP Annual Meeting
Improving Adherence with Treat to Target in Rheumatoid Arthritis through a Learning Collaborative: Rationale and Design of the Traction Trial
Daniel H. Solomon¹, Sara Lee², Agnes Zak², Jen Agosti³, Asaf Bitton⁴, Liana Fraenkel⁵, Leslie Harrold⁶, Elena Losina⁷, Bing Lu⁸, Theodore Pincus⁹, Josef S. Smolen¹⁰ and Jeffrey N. Katz¹¹, ¹Rheumatology, Brigham and Women's Hospital, Boston, MA, ²Brigham and Women's Hospital, Boston, MA, ³JRA Consulting, Andover, MA, ⁴Medicine, Brigham and Women's Hospital, Boston, MA, ⁵Medicine, Yale University School of Medicine, New Haven, CT, ⁶Dept of Medicine, UMass Medical School, Worcester, MA, ⁷Orthopedics, Brigham and Women's Hospital, BU School of Public Health and Harvard Medical School, Boston, MA, ⁸Rheumatology Immunology & Allergy, Brigham & Women's Hospital, Boston, MA, ⁹Medicine-Rheumatology, NYU Hospital for Joint Diseases, New York, NY, ¹⁰Medical University of Vienna, Vienna, Austria, ¹¹Brigham and Women's Hospital and Harvard Medical School, Boston, MA
Background/Purpose: Treat to target (TTT) is a recommended paradigm in the management of rheumatoid arthritis (RA). However, various data sources suggest that TTT is…
Abstract Number: 1027 • 2015 ACR/ARHP Annual Meeting
Rheumatoid Arthritis Disease Activity Assessment Frequencies in Clinical Practices Do Not Support Treat-to-Target Care
David Sikes¹, James Bower², Drew Johnson³, J. Timothy Harrington², Rafia Khalil⁴, Edmund LaCour⁵, Michael Naarendorp⁶, Hillary Norton⁷ and Kathleen Thomas⁸, ¹Rheumatology, Florida Medical Clinic PA, Zephyrhills, FL, ²Joiner Associates LLC, Madison, WI, ³Crescendo Bioscience, Inc., South San Francisco, CA, ⁴Rafia Khalil Arthritis & Rheumatology Center, PC, Port Huron, MI, ⁵Dothan Medical Associates PC, Dothan, AL, ⁶Harlem Rhematology, LLC, New York, NY, ⁷Rheumatology, Santa Fe Rheumatology, Santa Fe, NM, ⁸Community Rheumatology, Noblesville, IN
Background/Purpose: Treat-to-Target (T2T) recommendations for rheumatoid arthritis (RA) care include standardized frequencies of disease activity (DA) assessment based on DA level. For this study, "on…
Abstract Number: 1998 • 2015 ACR/ARHP Annual Meeting
A National Electronic Health Record-Enabled Registry in Rheumatology: The ACR’s Rheumatology Informatics System for Effectiveness (RISE)
Jinoos Yazdany¹, Rachel Myslinski², Melissa Francisco³, Nick Bansback⁴, Megan E. B. Clowse⁵, Deborah Collier⁶, Karen Law⁷, Katherine Liao⁸, Kaleb Michaud⁹, Esi Morgan-DeWitt¹⁰, Jim Oates¹¹, Catalina Orozco¹², Andreas Reimold¹³, Julia F Simard¹⁴ and Salahuddin Kazi¹⁵, ¹University of California, San Francisco, San Francisco, CA, ²Governance & Ethics Specialist, Amer College of Rheumatology, Atlanta, GA, ³Practice, Advocacy & Quality, American College of Rheumatology, Atlanta, GA, ⁴Population and Public Health, The University of British Columbia, Vancouver, BC, Canada, ⁵Clinical Rheumatologist, Duke University Medical Center, Durham, NC, ⁶Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁷Emory University School of Medicine, Atlanta, GA, ⁸Division of Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, Boston, MA, ⁹Rheumatology & Immunology, University of Nebraska Medical Center and National Data Bank, Omaha, NE, ¹⁰Pediatric rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ¹¹Medicine, Medical University of South Carolina, Charleston, SC, ¹²Arthritis Consultation Ctr, Dallas, TX, ¹³Rheumatology, VAMC, University of Texas Southwestern Medical Center, Dallas, TX, ¹⁴Division of Epidemiology, Health Research and Policy Department, and Division of Immunology & Rheumatology, Department of Medicine, Stanford School of Medicine, Stanford, CA, ¹⁵Internal Medicine/Rheumatology, UT Southwestern Medical Center, Dallas, TX
Title: A National Electronic Health Record-Enabled Registry in Rheumatology: The ACR's Rheumatology Informatics System for Effectiveness (RISE)Background/Purpose: In 2014, the ACR launched the Rheumatology Informatics…
Abstract Number: 2228 • 2015 ACR/ARHP Annual Meeting
Brief Educational Intervention Improves Gout Patients’ Understanding of Their Disease
Slavica Bobic¹, Mark Tratenberg¹, Julia Ash¹, Amy Wasserman² and Kirk Sperber¹, ¹Rheumatology, New York Medical College, Valhalla, NY, ²New York Medical College, Valhalla, NY
Background/Purpose: To assess gout patients’ baseline knowledge of their disease and to measure knowledge improvement after brief educational session. Methods: In this study, 13 patients…
Abstract Number: 2317 • 2015 ACR/ARHP Annual Meeting
Different Rheumatoid Arthritis Disease Activity Measures Often Provide Discordant Results in Clinical Practice Populations
Gary Crump¹, James Bower², Terrence Foley³, J. Timothy Harrington², Nikita Hegde⁴, Drew Johnson⁵, Rafia Khalil⁶, Edmund LaCour⁷ and Robert Perhala⁸, ¹Rheumatology Associates - Louisville, Louisville, KY, ²Joiner Associates LLC, Madison, WI, ³Terrence Foley MD Inc, Concord Twp, OH, ⁴Akron General Hospital, Cuyahoga Falls, OH, ⁵Crescendo Bioscience, Inc., South San Francisco, CA, ⁶Rafia Khalil Arthritis & Rheumatology Center, PC, Port Huron, MI, ⁷Dothan Medical Associates PC, Dothan, AL, ⁸University Hospitals, Cleveland, OH
Background/Purpose: Accurate rheumatoid arthritis (RA) disease activity assessment is required for treatment consistent with Treat-to-Target (T2T) recommendations. Rheumatologists currently use a variety of patient-generated, physician-generated,…
Abstract Number: 2487 • 2015 ACR/ARHP Annual Meeting
Clinical Practices Participating in a Quality Improvement Project Make Progress in Implementing Population Management
Erin Arnold¹, William Arnold¹, James Bower², Douglas Conaway³, J. Timothy Harrington², Drew Johnson⁴, James Mossell⁵, Joy Schechtman⁶ and Anne Winkler⁷, ¹Orthopedics and Rheumatology of the North Shore, Skokie, IL, ²Joiner Associates LLC, Madison, WI, ³Rheumatology/Medicine, Carolina Health Specialists, Myrtle Beach, SC, ⁴Crescendo Bioscience, Inc., South San Francisco, CA, ⁵Arthritis and Osteo Center of South Georgia, Tifton, GA, ⁶Sun Valley Arthritis Center LTD, Peoria, AZ, ⁷Rheumatology, Winkler Medical Practice LLC, Springfield, MO
Background/Purpose: Population management (PM) offers a promising approach to providing Treat-to-Target (T2T) care for rheumatoid arthritis (RA). PM depends on providing standardized, on-time disease activity…
Abstract Number: 2491 • 2015 ACR/ARHP Annual Meeting
Documentation of Disease Activity Score As Part of a Treat to Target Strategy in Rheumatoid Arthritis
Sarah Homann¹ and Beth Scholz², ¹Rheumatology, University of Texas Health Sciences Center at Houston, Houston, TX, ²University of Texas Health Sciences Center at Houston, Houston, TX
Background/Purpose: Compared to routine care, the Treat to Target (TTT) strategy for rheumatoid arthritis (RA) has been validated to improve functional and radiographic outcomes via…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].